PIR International’s EU/UK Biotech C-Suite Remuneration & Diversity Study is a data-driven resource that empowers executives, investors and boards with the insights they need to guide company governance, business strategy and strive for excellence. This strictly independent, anonymised and confidential remuneration study is designed to leverage participation from the entire European and UK biotech and life science ecosystem that will provide the very latest data to deliver important trends and analysis for all decision-makers in the sector.
Available November 2025, in collaboration with globally renowned law firm, Mishcon de Reya LLP, PIR International’s EU/UK Biotech C-Suite Remuneration & Diversity Study dissects remuneration, participation, equity, geographic and diversity representation, in correlation to key metrics such as investment level, founder status and other quantitative and qualitative measures. All aimed to give the latest and actionable insights for company governance in the European and UK biotech and life science sector.
